<DOC>
	<DOCNO>NCT02833415</DOCNO>
	<brief_summary>This study clinical study investigate gluconeogenesis pathway related visceral adipose tissue ( VAT ) obese individual without type 2 diabetes effect empagliflozin ( EMPA ) glucose homeostasis viscerally-obese individual use functional study glycerol metabolism hepatic gluconeogenesis use well-validated nuclear magnetic resonance ( NMR ) spectroscopy platform .</brief_summary>
	<brief_title>Visceral Adiposity Diabetes : Translating Form Function Using Imaging</brief_title>
	<detailed_description>Diabetes mellitus type II consequence insulin resistance pancreatic beta cell failure result variety metabolic insult , one excess body adiposity/obesity . In diabetic individual , hepatic gluconeogenesis may go uninhibited due failure body 's normal feedback mechanism appropriately incorporate glucose cell via insulin signaling , lead excess gluconeogenesis hyperglycemia . The substrate excess glucose derive multiple source liver include dietary glycerol , adipose-derived glycerol lipolysis , substrates citric acid cycle . In normal state , lipolysis maintain steady state equilibrium store dietary triglyceride free fatty acid . However , situation triglyceride excess ( e.g . obese state ) , lipolysis may become overactive result increased free fatty acid adipose-derived glycerol . This excess glycerol drive hepatic gluconeogenesis incorporate glucose release blood , lead hyperglycemia , ultimately diabetes clinical sequela . A popular hypothesis link visceral fat excess gluconeogenesis delivery glycerol arise mesenteric triglyceride turnover directly portal circulation liver . Glycerol primary substrate gluconeogenesis liver . Under normal condition , hepatic gluconeogenesis begin glycerol ingest diet converted glycerol-3-phosphate subsequently dihydroxyacetone phosphate ( DHAP ) liver . DHAP convert fructose-1,6-bisphosphate undergoes series reaction become single 6-carbon glucose molecule . Adipocytes contribute glycerol hepatic gluconeogenesis lipolysis triglyceride store . Although glycerol-gluconeogenesis extensively studied animal , traditional reliance radioactive tracer make translation human difficult many reason . We aim use new technique explore mechanism behind altered glucose metabolism relate excess visceral adiposity obese adult quantify relative contribution vary substrate liver-derived glucose . One method use 13C3 label glycerol trace incorporation glycerol dietary source hepatic gluconeogenesis . This technology utilizes nuclear magnetic resonance ( NMR ) spectroscopy , technique require ionize radiation extensively validate , analyze NMR spectrum plasma glucose quantify `` percent enrichment '' circulate glucose molecule label glycerol . In turn , difference enrichment reflect variability hepatic glucose metabolism relate contribution glycerol visceral adipose tissue gluconeogenesis . The rationale project utilize exist technology investigate impact excess visceral adiposity glycerol metabolism hepatic gluconeogenesis obese adult without diabetes explore effect treatment EMPA visceral adiposity relate glucose homeostasis .</detailed_description>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>Obese , define BMI â‰¥ 30 kg/m2 , time abdominal fat image study entry . Ages 3065 No prevalent diagnosis type 2 diabetes mellitus , either time abdominal fat image study entry . Previous abdominal fat quantification magnetic resonance image Dallas Heart Study possible necktoknee MRI VAT measurement may perform . Pregnant breastfeeding Incarcerated Chronic kidney liver disease History frequent ( &gt; 2/year ) urinary tract infection Nonobese either time abdominal fat image present . Greater 10 % change body weight ( kg ) time abdominal fat image present . Has donate blood within last 6 week Can give informed consent , understand protocol , tolerate aspect protocol If undergoing MRI , person metal implant contraindicate 3Tesla MRI exam exclude . Severe claustrophobia also assess prior MRI exam .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Visceral</keyword>
	<keyword>Obesity</keyword>
	<keyword>Adipose</keyword>
	<keyword>Diabetes</keyword>
</DOC>